Peregrine Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-114,533	Closed	-$3.3M	–	333
2024 Q3	$3.3M	Buy	114,533 +254	+0.2%	+$7.33K	0.1%	244
2024 Q2	$4.38M	Buy	114,279 +21,619	+23%	+$829K	0.13%	239
2024 Q1	$5.45M	Buy	+92,660	New	+$5.45M	0.16%	226